Publications by authors named "Lucy Ghoda"

14Publications

The changing investment in translational science by academic medical centers: HOPE in the Valley of Death.

J Clin Invest 2020 Jul;130(7):3333-3335

Comprehensive Cancer Center and Beckman Research Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI138640DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324205PMC
July 2020

Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia.

Leukemia 2020 01 23;34(1):75-86. Epub 2019 Jul 23.

Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope Medical Center and Beckman Research Institute, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0522-9DOI Listing
January 2020

Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis.

J Cell Physiol 2019 08 22;234(10):17612-17621. Epub 2019 Feb 22.

Department of Medical Biotechnology, Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City, Vietnam.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.28385DOI Listing
August 2019

The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML.

J Cell Physiol 2019 08 8;234(8):14040-14049. Epub 2019 Jan 8.

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.28091DOI Listing
August 2019

The role of ErbB3 binding protein 1 in cancer: Friend or foe?

J Cell Physiol 2018 12 4;233(12):9110-9120. Epub 2018 Aug 4.

Department of Medical Biotechnology, Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City, Vietnam.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.26951DOI Listing
December 2018

Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53.

Virol J 2011 Sep 5;8:422. Epub 2011 Sep 5.

Department of Pediatrics, Yale SOM, 488 Norton Parkway, New Haven, CT 06511, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1743-422X-8-422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180424PMC
September 2011

Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS).

Biologics 2007 Dec;1(4):425-32

Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721295PMC
December 2007

A review of recent patents concerning therapy of respiratory diseases using gene silencing by RNAi (RISC) and EGS (RNAse P).

Recent Pat Inflamm Allergy Drug Discov 2007 Feb;1(1):49-55

Pediatrics, Yale School of Medicine and Medical Director, Founder Keren Pharmaceutical Inc., 488 Norton Parkway, New Haven CT 06511, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/187221307779815147DOI Listing
February 2007

Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.

BMC Immunol 2005 Jun 21;6:12. Epub 2005 Jun 21.

Division of Basic Sciences, Department of Pediatrics, National Jewish Medical Research Center, Denver, CO 80262 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2172-6-12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1184076PMC
June 2005